Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha.

Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha. Abstract Text:

Naho Sasaki,Yukari Egashira,Hiroo Sanada,

BACKGROUND: alpha-Amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD) is a key enzyme in NAD biosynthesis from tryptophan. Dietary polyunsaturated fatty acids (PUFA) have been shown to suppress hepatic ACMSD activity and its mRNA level in rat. However the mechanism of the suppressive action has not been clarified yet. Although the phenomena that fatty acids suppress the expression of ACMSD in rat liver have been established in vivo experiment, it is still obscure whether the effect of fatty acids on the expression of the enzyme is caused by its direct or indirect action, because there have been very few investigations performed in vitro. AIM OF THE STUDY: In this study, to examine whether down-regulation of ACMSD mRNA by PUFA involves peroxisome proliferator-activated receptor (PPAR) alpha mediated mechanism or not, we investigated the effect of PUFA on the ACMSD expression by using primary cultured rat hepatocytes. METHODS: For this purpose we investigated the effect of PUFA (linoleic acid and eicosapentanoic acid) on the ACMSD mRNA level in primary-cultured rat hepatocytes and compared its effect with that of WY-14,643 (a PPARalpha agonist). After the incubation of hepatocytes with fatty acids, WY-14,643 and/or MK886 (a PPARalpha antagonist), mRNA levels of ACMSD and a peroxisome marker enzyme acyl-CoA oxidase (ACO) were determined by competitive reverse transcription-polymerase chain reaction (RT-PCR) method. RESULTS: ACMSD mRNA level in primary hepatocytes were decreased by the incubation with high concentrations of linoleic acid, eicosapentaenoic acid (EPA) and WY-14,643. The appearance of ACO mRNA by WY-14,643 was remarkably increased, and those by linoleic acid and EPA were increased less than that by WY-14,643. Moreover, the suppression of ACMSD mRNA and the augmentation of ACO mRNA by WY-14,643 were inhibited by MK886, but the suppression by PUFA was not substantially affected by MK886. CONCLUSIONS: The present study suggesting that the mechanism of decrease in ACMSD mRNA level by PUFA was different from that by WY-14,643, and that there would be any pathway other than PPARalpha mediated one for PUFA to regulate ACMSD expression.

Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha. Publishing Authors By Initials

N Sasaki,Y Egashira,H Sanada,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: European journal of nutrition

VOLUME: 47

Page Numbers: 80-6

Journal Abbreviation:

ISSN: 1436-6207

DAY: 4

MONTH: 03

YEAR: 2008

Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100888704

Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha.

AFFILIATION: Graduate School of Science and Technology, Chiba University, 648 Mastudo, Mastudo-shi, Chiba, 271 8510, Japan, naho.sasaki@gmail.com.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur J Nutr

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha Related Publications

• Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.
• Alkylation carcinogenesis in mice with altered levels of DNA repair methyltransferase.
• Amino acid sequences of glycopeptides obtained from basic proline-rich glycoprotein of human parotid saliva.
• Characteristics of proline oxidase in rat tissues.
• Characterization and amino acid sequence of a new acidic cysteine proteinase inhibitor (cystatin SA) structurally closely related to cystatin S, from human whole saliva.
• Complete amino acid sequence of a basic proline-rich peptide, P-D, from human parotid saliva.
• Complete amino acid sequence of a basic proline-rich peptide, P-F, from human parotid saliva.
• Comprehensive assessment of nutritional status and associated factors in the healthy, community-dwelling elderly.
• Cystatin S: a cysteine proteinase inhibitor of human saliva.
• Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha.
• Effect of dietary fiber in edible seaweeds on the development of d-galactosamine-induced hepatopathy in rats.
• Effects of various kinds of edible seaweeds in diets on the development of D-galactosamine-induced hepatopathy in rats.
• Fractionation and characterization of basic proline-rich peptides of human parotid saliva and the amino acid sequence of proline-rich peptide P-E.
• Further fractionation of basic proline-rich peptides from human parotid saliva and complete amino acid sequence of basic proline-rich peptide P-H.
• Imaging diagnosis of hepatic metastases of pancreatic carcinomas: significance of transient wedge-shaped contrast enhancement mimicking arterioportal shunt.
• Isolation and amino acid sequence of SAP-1, an acidic protein of human whole saliva, and sequence homology with human gamma-trace.
• Isolation and amino acid sequences of proline-rich peptides of human whole saliva.
• L-Gln and L-Ser suppress the D-galactosamine-induced IL-18 expression and hepatitis.
• Primary structure of cat osteocalcin.
• The amino acid sequence of a salivary proline-rich peptide, P-C, and its relation to a salivary proline-rich phosphoprotein, protein C.
• Thoracic cavernous malformations on T2*-weighted MR images.
• Ultrasonographic evaluation of an unusual peri-anal induration: a possible case of deep tissue injury.
• [A Case of Effective Weekly Paclitaxel Administration for Advanced Gastric Cancer Associated with Diabetes Mellitus -About the Control of Blood Glucose When Dexamethasone for Prophylaxis against Paclitaxel-Associated Hypersensitivity Reactions to the Diab
• [Ventricular septal perforation due to coronary artery spasm--a case report]